Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Treatment of Erectile Dysfunction II

ClinicalTrials.gov ID: NCT01037218

Public ClinicalTrials.gov record NCT01037218. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 2:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-controlled, Double-Blind, Parallel Design, Phase 3 Study to Assess the Safety and Efficacy of Udenafil Tablets in Male Subjects With Erectile Dysfunction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Randomized, placebo-controlled, double-blind, parallel design, Phase 3 study to evaluate the safety and efficacy of udenafil, an orally administered, potent and selective inhibitor of PDE-5 versus placebo for the treatment of subjects with erectile dysfunction (ED).

Study identification

NCT ID
NCT01037218
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Warner Chilcott
Industry
Enrollment
601 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
19 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2009 (Type not available)
Primary completion
Apr 2010 (Actual)
Completion
Apr 2010 (Actual)
Last update posted
Jun 19, 2015

2009 – 2010

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
39
Facility City State ZIP Site status
Warner Chilcott Investigational Site Birmingham Alabama 35209 —
Warner Chilcott Investigational Site Huntsville Alabama 35801 —
Warner Chilcott Investigational Site Tempe Arizona 85282 —
Warner Chilcott Investigational Site Chino California 91710 —
Warner Chilcott Investigational Site Tarzana California 91356 —
Warner Chilcott Investigational Site Englewood Colorado 80113 —
Warner Chilcott Investigational Site Milford Connecticut 06460 —
Warner Chilcott Investigational Site Aventura Florida 33180 —
Warner Chilcott Investigational Site Daytona Beach Florida 32114 —
Warner Chilcott Investigational Site DeLand Florida 32720 —
Warner Chilcott Investigational Site Ocala Florida 34471 —
Warner Chilcott Investigational Site Tampa Florida 33607 —
Warner Chilcott Investigational Site Dawsonville Georgia 30534 —
Warner Chilcott Investigational Site Sandy Springs Georgia 30328 —
Warner Chilcott Investigational Site Fort Wayne Indiana 46825 —
Warner Chilcott Investigational Site Greenwood Indiana 46143 —
Warner Chilcott Investigational Site West Des Moines Iowa 50266 —
Warner Chilcott Investigational Site Elkridge Maryland 21075 —
Warner Chilcott Investigational Site Greenbelt Maryland 20770 —
Warner Chilcott Investigational Site Las Vegas Nevada 89106 —
Warner Chilcott Investigational Site Lawrenceville New Jersey 08648 —
Warner Chilcott Investigational Site Bay Shore New York 11706 —
Warner Chilcott Investigational Site Brooklyn New York 11219 —
Warner Chilcott Investigational Site Kingston New York 12401 —
Warner Chilcott Investigational Site New York New York 10016 —
Warner Chilcott Investigational Site Poughkeepsie New York 12601 —
Warner Chilcott Investigational Site Williamsville New York 14221 —
Warner Chilcott Investigational Site Cary North Carolina 27518 —
Warner Chilcott Investigational Site Raleigh North Carolina 27609 —
Warner Chilcott Investigational Site Raleigh North Carolina 27612 —
Warner Chilcott Investigational Site Salisbury North Carolina 28144 —
Warner Chilcott Investigational Site Cleveland Ohio 44122 —
Warner Chilcott Investigational Site Jenkintown Pennsylvania 19046 —
Warner Chilcott Investigational Site Lancaster Pennsylvania 17604-3200 —
Warner Chilcott Investigational Site Greer South Carolina 29650 —
Warner Chilcott Investigational Site Arlington Texas 76017 —
Warner Chilcott Investigational Site San Antonio Texas 78229 —
Warner Chilcott Investigational Site Norfolk Virginia 23502 —
Warner Chilcott Investigational Site Richmond Virginia 23294 —
Warner Chilcott Investigational Site Mountlake Terrace Washington 98043 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01037218, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 19, 2015 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01037218 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →